BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32182616)

  • 1. Evaluation of Systemic Inflammatory Response and Nutritional Biomarkers as Predictive Factors in Patients with Recurrent Gastric Cancer.
    Namikawa T; Yokota K; Yamaguchi S; Iwabu J; Munekage M; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kumon M; Kobayashi M; Hanazaki K
    Oncology; 2020; 98(7):452-459. PubMed ID: 32182616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.
    Namikawa T; Munekage E; Munekage M; Maeda H; Yatabe T; Kitagawa H; Kobayashi M; Hanazaki K
    Oncology; 2016; 90(6):321-6. PubMed ID: 27225990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer.
    Namikawa T; Kawanishi Y; Fujisawa K; Munekage E; Iwabu J; Munekage M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Surg Today; 2018 Apr; 48(4):388-394. PubMed ID: 29043453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.
    Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Tamura T; Yatabe T; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Gastric Cancer; 2019 Jul; 22(4):684-691. PubMed ID: 30417313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination.
    Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J
    Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammatory response and nutritional biomarkers as predictors of nivolumab efficacy for gastric cancer.
    Namikawa T; Yokota K; Tanioka N; Fukudome I; Iwabu J; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Surg Today; 2020 Nov; 50(11):1486-1495. PubMed ID: 32542414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer.
    Wang Q; Yang Y; Zhang YP; Zou Z; Qian X; Liu B; Wei J
    Med Oncol; 2014 Dec; 31(12):289. PubMed ID: 25344872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Systemic Inflammatory Response and Nutritional Markers in Patients With Trastuzumab-treated Unresectable Advanced Gastric Cancer.
    Namikawa T; Maeda M; Yokota K; Tanioka N; Fukudome I; Iwabu J; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    In Vivo; 2020; 34(5):2851-2857. PubMed ID: 32871824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.
    Wu XS; Shi LB; Li ML; Ding Q; Weng H; Wu WG; Cao Y; Bao RF; Shu YJ; Ding QC; Mu JS; Gu J; Dong P; Liu YB
    Ann Surg Oncol; 2014 Feb; 21(2):449-57. PubMed ID: 24081806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.
    Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L
    Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.
    Abbas M; Ahmed A; Khan GJ; Baig MMFA; Naveed M; Mikrani R; Cao T; Naeem S; Shi M; Dingding C
    Curr Probl Cancer; 2019 Feb; 43(1):5-17. PubMed ID: 30172422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
    Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.